Arthritis Autoimmunity Case reports Active Amyotrophy Inflammatory myopathy Auto‐antibodies Myositis Anti‐mitochondrial antibodies AAV Antisynthetase Anti-IgE IgG Muscle Biomarkers Acute Kidney Injury/epidemiology/etiology Male Biomarqueurs Gene therapy AAV antibody Anticorps spécifique des myosites Antibody responses Anti-MDA5 autoantibodies Adverse drug reactions Myopathy Dermatomyositis Adult Cancer Machine learning Data integration Biopsy Autoimmune diseases IBM Prognosis Multidisciplinarity Outcome measures Fabry disease Adeno-associated vector Mass cytometry Adjudication Deep immune profiling Humans Anti-drug antibodies Anti-interleukin-6 Antiphospholipid syndrome Inborn errors of metabolism Pharmacology Skeletal muscle Anti-Mi2 DM Idiopathic inflammatory myopathies Interstitial lung disease Auto-antibodies Myocarditis Auto-immunité IMNM Polymyositis Cytokines Agalsidase Antisynthetase syndrome Animals Immune checkpoint inhibitors B cell homeostasis Anémie hémolytique Myositis and muscle disease Aldostérone AAV humoral immunity Acid-alpha-glucosidase Amyotrophic lateral sclerosis Interferon Lysosomal storage diseases Antibodies Abnormal movement Inclusion body myositis Anti-synthetase syndrome Biomarker Middle Aged Immunotherapy Adeno-associated virus vector Autoantibodies Autoantibody B-lymphocyte Analyses multidimensionnelles Inflammation AAV vector Systems biology Adolescence Assisted communication devices Anti-agalsidase antibodies Bioelectrical impedance analysis Cardio-oncology Adeno-associated virus Female Antisynthétase Aged Sphingosine-1-phosphate Dependovirus/genetics/immunology Aldosterone COVID-19 Anticorps anti-agalsidase AAV vectors